Skip to main content
. Author manuscript; available in PMC: 2020 May 5.
Published in final edited form as: ACS Appl Mater Interfaces. 2019 Nov 13;11(47):43879–43887. doi: 10.1021/acsami.9b15195

Figure 4.

Figure 4.

Region-of-interest quantification and biodistribution studies. Comparison of (A) tumor uptake, (B) tumor-to-blood ratios, (C) tumor-to-liver ratios, and (D) tumor-to-muscle ratios between targeted (LNCap) and nontargeted (PC-3) cohorts (n = 5 for each group). (E) Biodistribution of 89Zr-DFO-PSMAi-PEG-Cy5-C′ dots in LNCap or PC-3 tumor-bearing mice at 72 h p.i. (**p < 0.005).